These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6743467)

  • 1. Comparison of two long-acting forms of quinidine.
    Leizorovicz A; Piolat C; Boissel JP; Sanchini B; Ferry S
    Br J Clin Pharmacol; 1984 Jun; 17(6):729-34. PubMed ID: 6743467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.
    Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Mussini A; Salerno J
    Br J Clin Pharmacol; 1977 Aug; 4(4):449-54. PubMed ID: 901736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of quinidine in two sustained-release preparations.
    Garty M; Rachmel A; Ilfeld D; Sinai Y; Paz R
    Isr J Med Sci; 1992 Jun; 28(6):357-61. PubMed ID: 1607272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relative bioavailability and influence of a quinidine retard-formulation on blood-pressure and ECG in healthy volunteers (author's transl)].
    Knapp W; Lechleitner P
    Arzneimittelforschung; 1981; 31(9):1482-6. PubMed ID: 7197960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.
    Holford NH; Coates PE; Guentert TW; Riegelman S; Sheiner LB
    Br J Clin Pharmacol; 1981 Feb; 11(2):187-95. PubMed ID: 7213522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bioequivalence study of a new nifedipine containing retard filmtablet after single and repeated administration.
    Klebovich I; Drabant S; Horvai G; Nemes KB; Grézal G; Horváth V; Hrabéczy-Páll A; Kocsi E; Cseh A; Balogh J; Farsang C
    Arzneimittelforschung; 1997 May; 47(5):598-603. PubMed ID: 9205772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.
    Regårdh CG; Johnsson G; Lundborg P; Perrson BA
    Arzneimittelforschung; 1977; 27(9):1716-8. PubMed ID: 21671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of Kinidin-Durules preparation in the prevention of recurrent atrial fibrillation].
    Staśkiewicz J; Rymar B; Rumiński W
    Pol Tyg Lek; 1975 Apr; 30(17):725-6. PubMed ID: 1135029
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained-release quinidine (Kinidin Durules) in maintaining sinus rhythm after electroversion of atrial dysrhythmias.
    Resnekov L; Gibson D; Waich S; Muir J; McDonald L
    Br Heart J; 1971 Mar; 33(2):220-5. PubMed ID: 5572656
    [No Abstract]   [Full Text] [Related]  

  • 10. Simple-to-use, reference criteria for revealing drug-induced QT interval prolongation in conscious dogs.
    Schmitt MW; Von Landenberg F; Poth H; Wimmer E; Goddemeier T; Cavero I
    Eur J Pharmacol; 2007 Jan; 554(1):46-52. PubMed ID: 17112506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG.
    Wolpert C; Schimpf R; Giustetto C; Antzelevitch C; Cordeiro J; Dumaine R; Brugada R; Hong K; Bauersfeld U; Gaita F; Borggrefe M
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):54-8. PubMed ID: 15673388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of short-acting and long-acting quinidine for maintenance of sinus rhythm after electrical conversion of atrial fibrillation.
    Normand JP; Legendre M; Kahn JC; Bourdarias JP; Mathivat A
    Br Heart J; 1976 Apr; 38(4):381-7. PubMed ID: 773392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of three commercial quinidine dosage forms.
    Sirois G; Eshaque M; Chabot M
    Biopharm Drug Dispos; 1980; 1(4):167-77. PubMed ID: 7448345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioequivalence of generic drugs and substitution: example of depot verapamil].
    Rietbrock N; Fischer A; Menke G
    Z Kardiol; 1987 Oct; 76(10):621-5. PubMed ID: 3318196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S; Uematsu T; Guentert TW; Ha HR; Follath F
    Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability study of three sustained release quinidine formulations.
    Mahon WA; Leeder JS; Brill-Edwards MM; Correia J; MacLeod SM
    Clin Pharmacokinet; 1987 Aug; 13(2):118-24. PubMed ID: 3621768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro recording of adult zebrafish heart electrocardiogram - a platform for pharmacological testing.
    Tsai CT; Wu CK; Chiang FT; Tseng CD; Lee JK; Yu CC; Wang YC; Lai LP; Lin JL; Hwang JJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1963-7. PubMed ID: 21767531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.